Ludwig Roman, Schubert Adrian, Barbatei Dorothea, Bauwens Laurence, Werlen Sandrine, Elicin Olgun, Dettmer Matthias, Zrounba Philippe, Balermpas Panagiotis, Pouymayou Bertrand, Grégoire Vincent, Giger Roland, Unkelbach Jan
Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
Department of ENT, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, CH-3010 Bern, Switzerland.
Data Brief. 2023 Dec 29;52:110020. doi: 10.1016/j.dib.2023.110020. eCollection 2024 Feb.
We provide a dataset on lymph node metastases in 968 patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC). All patients received neck dissection and we report the number of metastatic versus investigated lymph nodes per lymph node level (LNL) for every individual patient. Additionally, clinicopathological factors including T-category, primary tumor subsite (ICD-O-3 code), age, and sex are reported for all patients. The data is provided as three datasets: Dataset 1 contains 373 HNSCC patients treated at Centre Léon Bérard (CLB), France, with primary tumor location in the oral cavity, oropharynx, hypopharynx, and larynx. Dataset 2 contains 332 HNSCC patients treated at the Inselspital, Bern University Hospital (ISB), Switzerland with primary tumor location in the oral cavity, oropharynx, hypopharynx, and larynx. For these patients, additional information is provided including lateralization of the primary tumor, size and location of the largest metastases, and clinical involvement based on computed tomography (CT), magnetic resonance imaging (MRI), and/or 18FDG-positron emission tomography (PET/CT) imaging. Dataset 3 consists of 263 oropharyngeal SCC patients underlying a previous publication by Bauwens et al. [1], which were treated at CLB. For these patients, additional information including HPV status, lateralization of the primary tumor and clinically diagnosed lymph node involvement is provided.
The data may be used to quantify the probability of occult lymph node metastases in each LNL, depending on an individual patient's characteristics of the primary tumor and the location of clinically diagnosed lymph node metastases. As such, the data may contribute to further personalize the elective treatment of the neck for HNSCC patients, i.e. definition of the elective clinical target volume (CTV-N) in radiotherapy (RT) and the extent of neck dissection (ND) in surgery. There exists only one similar publicly available dataset that reports clinical involvement per LNL in 287 oropharyngeal SCC patients [2]. The data presented in this article substantially extends the available data, it additionally includes pathologically assessed involvement per LNL, and it provides data for multiple subsites in the head and neck region.
我们提供了一个关于968例新诊断的头颈部鳞状细胞癌(HNSCC)患者淋巴结转移情况的数据集。所有患者均接受了颈清扫术,我们报告了每位患者每个淋巴结水平(LNL)的转移淋巴结数量与检查的淋巴结数量。此外,还报告了所有患者的临床病理因素,包括T分类、原发肿瘤亚部位(ICD-O-3编码)、年龄和性别。数据以三个数据集的形式提供:数据集1包含373例在法国里昂贝拉尔中心(CLB)接受治疗的HNSCC患者,原发肿瘤位于口腔、口咽、下咽和喉部。数据集2包含332例在瑞士伯尔尼大学医院因塞尔医院(ISB)接受治疗的HNSCC患者,原发肿瘤位于口腔、口咽、下咽和喉部。对于这些患者,还提供了额外信息,包括原发肿瘤的侧别、最大转移灶的大小和位置,以及基于计算机断层扫描(CT)、磁共振成像(MRI)和/或18氟脱氧葡萄糖正电子发射断层扫描(PET/CT)成像的临床受累情况。数据集3由263例口咽鳞状细胞癌患者组成,这些患者来自Bauwens等人[1]之前发表的一篇文章,他们在CLB接受治疗。对于这些患者,还提供了额外信息,包括人乳头瘤病毒(HPV)状态、原发肿瘤的侧别和临床诊断的淋巴结受累情况。
根据个体患者的原发肿瘤特征和临床诊断的淋巴结转移位置,这些数据可用于量化每个LNL中隐匿性淋巴结转移的概率。因此,这些数据可能有助于进一步对头颈部鳞状细胞癌患者的颈部选择性治疗进行个性化,即在放射治疗(RT)中定义选择性临床靶区(CTV-N)以及在手术中确定颈清扫术(ND)的范围。目前只有一个类似的公开可用数据集报告了287例口咽鳞状细胞癌患者每个LNL的临床受累情况[2]。本文所呈现的数据大幅扩展了现有数据,它还包括每个LNL的病理评估受累情况,并提供了头颈部多个亚部位的数据。